Chicago, IL · Founded 2019 · Privately Held (backing)
Operator of a biopharmaceutical company intended to discover and develop next-generation medicines for neurodegenerative diseases. Vanqua Bio is based in Chicago, IL and was founded in 2019. Its last known valuation is $270 million. It has raised $149 million across 2 recorded rounds; the latest was a $45 million early-stage round in Feb 2024.
Last price · $/share
—
Implied valuation
$270.0M
Total raised
$149.0M
Last round
Early Stage VC
Feb 2024
Team — not yet on record
No current team members for Vanqua Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vanqua Bio with a free account
·The complete investor list: 12 names
·Watch Vanqua Bio: the Monday email on marks, rounds and moves
